A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  • Observational [Patient Registry]
  • Recruiting
  • NCT02954094
Eligibility Details Visit Clinicaltrials.gov

A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma (HCC)

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Gender
All

Age Group
18 Years and up

Accepting Healthy Volunteers?
No

Inclusion Criteria:

         1. Male or female patients, age ≥18 years

         2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

        Exclusion Criteria:

        1. Inability to provide written informed consent

At a Glance

National Government IDNCT02954094

IRB#IRB17-0129

Lead SponsorTarget PharmaSolutions, Inc.

Lead PhysicianAnjana A Pillai

Collaborator(s)N/A

EligibilityAll
18 Years and up
Recruiting